Esche C - Search Results

1

CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth.

Esche C, Gambotto A, Satoh Y, Gerein V, Robbins PD, Watkins SC, Lotze MT, Shurin MR. Esche C, et al. Eur J Immunol. 1999 Jul;29(7):2148-55. doi: 10.1002/(SICI)1521-4141(199907)29:07<2148::AID-IMMU2148>3.0.CO;2-F. Eur J Immunol. 1999. PMID: 10427977 Free article.

2

Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.

Satoh Y, Esche C, Gambotto A, Shurin GV, Yurkovetsky ZR, Robbins PD, Watkins SC, Todo S, Herberman RB, Lotze MT, Shurin MR. Satoh Y, et al. Among authors: esche c. J Exp Ther Oncol. 2002 Nov-Dec;2(6):337-49. doi: 10.1046/j.1359-4117.2002.01050.x. J Exp Ther Oncol. 2002. PMID: 12440225

3

Antitumor activities of IL-12 and mechanisms of action.

Shurin MR, Esche C, Péron JM, Lotze MT. Shurin MR, et al. Among authors: esche c. Chem Immunol. 1997;68:153-74. doi: 10.1159/000058690. Chem Immunol. 1997. PMID: 9329221 Review. No abstract available.

4

FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.

Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR. Esche C, et al. Cancer Res. 1998 Feb 1;58(3):380-3. Cancer Res. 1998. PMID: 9458075

5

FLT3-ligand administration inhibits liver metastases: role of NK cells.

Péron JM, Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR. Péron JM, et al. Among authors: esche c. J Immunol. 1998 Dec 1;161(11):6164-70. J Immunol. 1998. PMID: 9834102

6

Tumor's other immune targets: dendritic cells.

Esche C, Lokshin A, Shurin GV, Gastman BR, Rabinowich H, Watkins SC, Lotze MT, Shurin MR. Esche C, et al. J Leukoc Biol. 1999 Aug;66(2):336-44. doi: 10.1002/jlb.66.2.336. J Leukoc Biol. 1999. PMID: 10449178

7

Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.

Ohm JE, Shurin MR, Esche C, Lotze MT, Carbone DP, Gabrilovich DI. Ohm JE, et al. Among authors: esche c. J Immunol. 1999 Sep 15;163(6):3260-8. J Immunol. 1999. PMID: 10477595

8

Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligand.

Esche C, Subbotin VM, Hunter O, Peron JM, Maliszewski C, Lotze MT, Shurin MR. Esche C, et al. J Invest Dermatol. 1999 Dec;113(6):1028-32. doi: 10.1046/j.1523-1747.1999.00779.x. J Invest Dermatol. 1999. PMID: 10594747 Free article.

9

Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

Lotze MT, Shurin M, Esche C, Tahara H, Storkus W, Kirkwood JM, Whiteside TL, Elder EM, Okada H, Robbins P. Lotze MT, et al. Among authors: esche c. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S61-6. Cancer J Sci Am. 2000. PMID: 10685662 Review.

10

Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.

Pirtskhalaishvili G, Shurin GV, Gambotto A, Esche C, Wahl M, Yurkovetsky ZR, Robbins PD, Shurin MR. Pirtskhalaishvili G, et al. Among authors: esche c. J Immunol. 2000 Aug 15;165(4):1956-64. doi: 10.4049/jimmunol.165.4.1956. J Immunol. 2000. PMID: 10925278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters